Type
. Modulation of human lepromatous monocyte-macrophage functions in vitro by tuftsin. International journal of immunopharmacology. 1990;12(8):847-58.
Type
. A time-dependent logistic hazard function for modeling variable age of onset in analysis of familial diseases. Genetic epidemiology. 1990;7(6):391-407.
Type
. [Polyarthritis in leprosy (author's transl)]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris. 1979;55(41-42):1889-92.
Type
. Serum angiotensin-converting enzyme, transcobalamin and lysozyme in normal and lepromatous armadillos. Journal of the Reticuloendothelial Society. 1979;26(4):367-72.
Type
. [Correlation between dyslipoproteinemia and coronary risk. Therapeutic effect of essential phospholipids on LDL/HDL]. Die Medizinische Welt. 1979;30(48):1827-32.
Type
. Immunotherapy for leprosy. Archives of dermatology. 1977;113(12):1731.
Type
. Major histocompatibility complex class II antigen expression in nerves in leprosy; an immunoelectronmicroscopical study. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1990;58(3):560-5. Available from: http://ila.ilsl.br/pdfs/v58n3a15.pdf
Type
. A study of autoantibodies in chronic mycobacterial infections. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1990;58(3):518-25. Available from: http://ila.ilsl.br/pdfs/v58n3a09.pdf
Type
. Treating leprosy in Amazonas. Nursing times. 1990;86(35):60-2.
Type
. A study on nutrition, growth and development of a high-risk group of children of urban leprosy patients. European journal of clinical nutrition. 1990;44(6):471-9.